[Utility of PET/CT in evaluation of haed and neck carcinoma--preliminary report on the basis of presented cases].
18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) offers advantages over PET alone, which is limited by poor anatomic localization and CT alone, which provides morphologic data only. Fusion of PET and CT images allows for precise target delineation for head and neck cancer compared with CT alone. The aim of this article is to evaluate the effect of the use of PET/CT in patients with head and neck cancer. We present four patients whose management was influenced by the implementation of combined PET/CT imaging. We conclude that PET/CT allows detection of recurrent neoplasm, carcinoma of unknown origin, second primary sites, distant metastases, tumor surveillance, staging, and planning radiation therapy.
Wierzbicka
Małgorzata
M
Klinika Otolaryngologii i Onkologii Laryngologicznej Uniwersytetu Medycznego w Poznaniu.
Popko
Mariola
M
Czepczyński
Rafał
R
Szyfter
Witold
W
D000328:Adult; D005260:Female; D019788:Fluorodeoxyglucose F18; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18